Piramal Health Care
- All
- News
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
GlaxoSmithKline's Rs 6,400-crore FDI proposal cleared by investment board: report
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
GlaxoSmithKline's Rs 6,400-crore FDI proposal cleared by investment board: report
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
